This was offset by fair value gain on financial assets at fair value through profit or loss of $0.13 million. In the same period a year ago, this figure stood at $0.83 million.
HC Surgical Specialists (HCSS) has reported lower earnings of $3.38 million for the 1HFY2025 ended Nov 30, 2024, a 2.1% decrease from $3.45 million in the same period a year ago.
This is mainly due to non-operational items, including a fair value loss on derivative financial instruments of approximately $0.43 million, and a loss arising from deemed disposal in an associate of $0.20 million.
